Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M. Polo Zarzuela"'
Autor:
T. Bernal, G. Rad, A. de Laiglesia, C. Benavente, A. Garcia Noblejas, D. Garcia Belmonte, R. Riaza, O. Salamero, A. Foncillas, A. Roldán, V. Noriega Concepcion, J. Perez de Oteyza, J. M. Bergua Burgues, S. Lorente de Uña, A. de la Fuente Burguera, M. J. Garcia Perez, J. L. Lopez Lorenzo, P. Martinez, C. Alaez, M. Callejas, C. Martinez Chamorro, J. Rifon Roca, L. Amador Barciela, M. Lopez, K. Gomez Correcha, E. Lavilla Rubiera, M. L. Amigo, F. Vall-Llovera, A. Garrido, M. Garcia Fortes, D. de Miguel Llorente, A. Aules Leonardo, C. Cervero, R. Coll Jorda, M. Perez Encinas, M. Polo Zarzuela, D. Martinez Cuadron, P. Montesinos
Publikováno v:
HemaSphere, Vol 6, Pp 407-408 (2022)
Externí odkaz:
https://doaj.org/article/e643e3a07df648d18344c9529230aecd
Publikováno v:
Revista Clínica Española (English Edition). 214:403-409
In recent years, there has been a significant improvement in the survival of patients with cancer in intensive care units (ICUs). Advances in medical and surgical treatments and better selection of patients has helped improve the life expectancy of t
Publikováno v:
Revista Clínica Española. 214:403-409
Resumen Durante los ultimos anos, se ha evidenciado una mejoria significativa en la supervivencia de los pacientes con cancer en las unidades de cuidados intensivos (UCI). Tanto el avance en el tratamiento medico y quirurgico, como una mejor seleccio
Autor:
C Grande-García, Anna Sureda, José Ramón González-Porras, Jose A. Rodriguez, M Polo-Zarzuela, Ramón García-Sanz, O N Gutiérrez, Cristina Barrenetxea, A Alegre, R. López, J F San Miguel, J M Hernández, M Vargas-Pabón, Luis Palomera
Publikováno v:
Leukemia. 18:856-863
We evaluate the efficacy of the oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) in 71 refractory/relapsed multiple myeloma patients, including a prognostic analysis to predict both response and survival. Patients receiv
Publikováno v:
Revista clinica espanola. 214(7)
In recent years, there has been a significant improvement in the survival of patients with cancer in intensive care units (ICUs). Advances in medical and surgical treatments and better selection of patients has helped improve the life expectancy of t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Palacios-Ortega M; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Guerra-Galán T; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Jiménez-Huete A; Department of Neurology, Clínica Universidad de Navarra, Madrid, Spain., García-Aznar JM; Department of Immunology, Health in Code, A Coruña, Spain., Pérez-Guzmán M; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Mansilla-Ruiz MD; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Mendiola ÁV; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., López CP; Department of Immunology, Health in Code, A Coruña, Spain., Hornero EM; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Rodriguez AP; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Cortijo AP; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Polo Zarzuela M; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Morales MM; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Mandly EA; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Cárdenas MC; Department of Biochemistry, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Carrero A; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain., García CJ; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Bolaños E; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Íñigo B; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., Medina F; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., de la Fuente E; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Ochoa-Grullón J; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., García-Solís B; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain.; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, 28046, Spain., García-Carmona Y; Division of Clinical Immunolgy, Mount Sinai Medical Center, New York, NY, USA., Fernández-Arquero M; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain., Benavente-Cuesta C; Department of Hematology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain., de Diego RP; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain.; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, 28046, Spain., Rider N; Division of Clinical Informatics, Pediatrics, Allergy and Immunology, Liberty University College of Osteopathic Medicine and Collaborative Health Partners, Lynchburg, Va, USA., Sánchez-Ramón S; Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos, Madrid, Spain. ssramon@salud.madrid.org.; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain. ssramon@salud.madrid.org.; Interdepartmental Unit of Immunodeficiencies, Madrid, Spain. ssramon@salud.madrid.org.; Department of Clinical Immunology, Laboratory Medicine Institute Hospital Clínico San Carlos and IdISSC, Calle Profesor Martín Lagos SN, Madrid, 28040, Spain. ssramon@salud.madrid.org.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Oct 23; Vol. 45 (1), pp. 32. Date of Electronic Publication: 2024 Oct 23.